Thermographic study of in vivo modulation of vascular responses to phenylephrine and endothelin-1 by dexamethasone in the horse

Handbook of Environmental Chemistry, Volume 5: Water Pollution

Volumn 38, Issue 2, 2006, Pages 119-126

  Cornelisse, C J ^a   Robinson, N E ^a   Berney, C A ^a   Eberhart, S ^a   Hauptman, J E ^a   Derksen, F J ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Dexamethasone; Endothelin; Horse; Intradermal; Phenylephrine; Thermography; Vascular function

Indexed keywords

EQUIDAE; EQUUS CABALLUS;

ANTIINFLAMMATORY AGENT; DEXAMETHASONE; ENDOTHELIN 1; PHENYLEPHRINE; VASOCONSTRICTOR AGENT;

ANIMAL; ANIMAL DISEASE; AREA UNDER THE CURVE; ARTICLE; BODY TEMPERATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG EFFECT; FEMALE; HORSE; METHODOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; SKIN; THERMOGRAPHY; VASCULARIZATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; AREA UNDER CURVE; BODY TEMPERATURE; CROSS-OVER STUDIES; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; FEMALE; HORSES; PHENYLEPHRINE; SKIN; THERMOGRAPHY; VASOCONSTRICTOR AGENTS;

EID: 33947322035     PISSN: 14336863     EISSN: 04251644     Source Type: Book Series    
DOI: 10.2746/042516406776563251     Document Type: Article

References (55)

1. Andersen, P., Milioni, K. and Maibach, H. (1993) The cutaneous corticosteroid vasoconstriction assay: a reflectance spectroscopic and laser-Doppler flowmetric study. Br. J. Dermatol. 128, 660-665.
2. Benamou, A.E., Marlin, D.J., Callingham, B.C., Hiley, R.C. and Lekeux, R. (2003) Spasmogenic action of endothelin-1 on isolated equine pulmonary artery and bronchus. Equine vet. J. 35, 190-196.
3. Bornmyr, S., Svensson, H., Lilja, B. and Sundkvist, G. (1997) Skin temperature changes and changes in skin blood flow monitored with laser Doppler flowmetry and imaging: a methodological study in normal humans. Clin. Physiol. 17, 71-81.
4. Bowen, I.M., Marr, C.M., Chester, A.H., Wheeler-Jones, C.P. and Elliott, J. (2004) In-vitro contraction of the equine aortic valve. J. Heart Valve Dis. 13, 593-599.
5. Brown, P.H., Teelucksingh, S., Matusiewicz, S.P., Greening, A.P., Crompton, G.K. and Edwards, C.R. (1991) Cutaneous vasoconstrictor response to glucocorticoids in asthma. Lancet 337, 576-580.
6. Clark, S., Dunn, G., Moore, T., Jayson, M.T., King, T.A. and Herrick, A.L. (2003) Comparison of thermography and laser Doppler imaging in the assessment of Raynaud's phenomenon. Microvasc. Res. 66, 73-76.
7. Clough, G.F. (1999) Role of nitric oxide in the regulation of microvascular perfusion in human skin in vivo. J. Physiol. 516, 549-557.
8. Cornelisse, C.J. and Robinson, N.E. (2004) Glucocorticoid therapy and equine laminitis: fact or fiction? Equine vet. Educ. 16, 90-93.
9. Di Filippo, C., Rossi, F., Ongini, E., Del Soldato, P., Perretti, M. and D'Amico, M. (2004) The distinct alterations produced in cardiovascular functions by prednisolone and nitro-prednisolone (NCX-1015) in the rat highlight a causal role for endothelin-1. J. Pharmacol. expt. Ther. 310, 1133-1141.
10. Elliott, J., Bryant, C.E. and Soydan, J. (1994) The role of nitric oxide in the responses of equine digital veins to vasodilator and vasoconstrictor agents. Equine vet. J. 26, 378-384.
11. Eyre, P., Elmes, P.J. and Strickland, S. (1979) Corticosteroid- potentiated vascular responses of the equine digit: a possible pharmacologic basis for laminitis. Am. J. vet. Res. 40, 135-138.
12. French, K., Pollitt, C.C. and Pass, M.A. (2000) Pharmacokinetics and metabolic effects of triamcinolone acetonide and their possible relationships to glucocorticoid-induced laminitis in horses. J. vet. Pharmacol. Ther. 23, 287-292.
13. Gerber, H. (1970) [Side effects of corticosteroid treatment in large animals]. Schweiz. Arch. Tierheilk. 112, 51-58.
14. Haigh, R.M. and Jones, C.T. (1990) Effect of glucocorticoids on alpha 1-adrenergic receptor binding in rat vascular smooth muscle. J. Mol. Endocrinol. 5, 41-48.
15. Harrison, D.K., Abbot, N.C., Beck, J.S. and McCollum, P.T. (1994) Laser Doppler perfusion imaging compared with light-guide laser Doppler flowmetry, dynamic thermographic imaging and tissue spectrophotometry for investigating blood flow in human skin. Adv. expt. Med. Biol. 345, 853-859.
16. Hocher, B., Schwarz, A., Slowinski, T., Bachmann, S., Pfeilschifter, J., Neumayer, H.H. and Bauer, C. (2004) In-vivo interaction of nitric oxide and endothelin. J. Hypertens. 22, 111-119.
17. Hood, D.M., Amoss, M.S. and Hightower, D. (1978) Equine laminitis I: Radioisotopic analysis of the hemodynamics of the footduring the acute phase. J. equine Med. Surg. 2, 439-444.
18. Ialenti, A., Calignano, A., Carnuccio, R. and Di Rosa, M. (1986) Glucocorticoid induction of angiotensin converting enzyme. Agents Actions 17, 294-295.
19. Kanse, S.M., Takahashi, K., Warren, J.B., Ghatei, M. and Bloom, S.R. (1991) Glucocorticoids induce endothelin release from vascular smooth muscle cells but not endothelial cells. Eur. J. Pharmacol. 199, 99-101.
20. Kato, H., Hayashi, T., Koshino, Y., Oida, K., Kutsumi, Y., Nakai, T. and Miyabo, S. (1995) Autocrine production of endothelin-1 participates in the glucocorticoid-induced Ca2+ influx into vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 208, 82-88.
21. Katugampola, R., Church, M.K. and Clough, G.F. (2000) The neurogenic vasodilator response to endothelin-1: a study in human skin in vivo. Expt. Physiol. 85, 839-846.
22. Katz, L.M., Marr, C.M. and Elliott, J. (2003) Characterization and comparison of the responses of equine digital arteries and veins to endothelin-1. Am. J. vet. Res. 64, 1438-1443.
23. Koshino, Y., Hayashi, T., Matsukawa, S., Asazuma, K., Eguchi, K., Kato, H., Nakai, T. and Miyamori, I. (1998) Dexamethasone modulates the expression of endothelin-1 and -A receptors in A7r5 vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 32, 665-672.
24. Lawrence, E. and Brain, S.D. (1994) Effect of BQ-123 and Ro 47-0203 (bosentan) on endothelin-induced vasoconstriction in the rat skin. Eur. J. Pharmacol. 260, 103-106.
25. Lenders, J.W., Golczynska A. and Goldstein, D.S. (1995) Glucorticoids, sympathetic activity, and presynaptic alpha 2-adrenoceptor function in humans. J. Clin. Endocrinol. Metab. 80, 720-725.
26. Leslie, S.J., Rahman, M.Q., Denvir, M.A., Newby, D.E. and Webb, D.J. (2004) Endothelins and their inhibition in the human skin microcirculation: ET[1-31], a new vasoconstrictor peptide. Br. J. Clin. Pharmacol. 57, 720-725.
27. B receptors. Am. J. Physiol. 276, H359-367.
28. Liu, J., Haigh, R.M. and Jones, C.T. (1992) Enhancement of noradrenaline-induced inositol polyphosphate formation by glucocorticoids in rat vascular smooth muscle cells. J. Endocrinol. 133, 405-411.
29. Macefield, V.G., Williamson, P.M., Wilson, L.R., Kelly, J.J., Gandevia, S.C. and Whitworth, J.A. (1998) Muscle sympathetic vasoconstrictor activity in hydrocortisone-induced hypertension in humans. Blood Press. 7, 215-222.
30. Mather, K.J., Lteif, A., Steinberg, H.O. and Baron, A.D. (2004) Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes. Diabetes 53, 2060-2066.
31. Morgan, K. (1998) Thermoneutral zone and critical temperatures of horses. J. Therm. Biol. 23, 59-61.
32. Morin, C., Asselin, C., Boudreau, F. and Provencher, P.H. (1998) Transcriptional regulation of pre-pro-endothelin-1 gene by glucocorticoids in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 244, 583-587.
33. Nambi, P., Pullen, M., Wu, H.L., Nuthulaganti, P., Elshourbagy, N. and Kumar, C. (1992) Dexamethasone down-regulates the expression of endothelin receptors in vascular smooth muscle cells. J. Biol. Chem. 267, 19555-19559.
34. Noon, J.P., Evans, C.E., Haynes, W.G., Webb, D.J. and Walker, B.R. (1996) A comparison of techniques to assess skin blanching following the topical application of glucocorticoids. Br. J. Dermatol. 134, 837-842.
35. Pang, C.Y., Zhang, J., Xu, H., Lipa, J.E., Forrest, C.R. and Neligan, P.C. (1998) Role and mechanism of endothelin-B receptors in mediating ET-1-induced vasoconstriction in pig skin. Am. J. Physiol. 275, R1066-1074.
36. Pass, M.A., Pollitt, S. and Pollitt, C.C. (1998) Decreased glucose metabolism causes separation of hoof lamellae in vitro: a trigger for laminitis? Equine vet. J., Suppl. 26, 133-138.
37. Provencher, P.H., Saltis, J. and Funder, J.W. (1995) Glucocorticoids but not mineralocorticoids modulate endothelin-1 and angiotensin II binding in SHR vascular smooth muscle cells. J. Steroid Biochem. Mol. Biol. 52, 219-225.
38. Robinson, N.E., Scott, J.B., Dabney, J.M. and Jones, G.A. (1976) Digital vascular responses and permeability in equine alimentary laminitis. Am. J. vet. Res. 37, 1171-1176.
39. Robinson, N.E., Dabney, J.M., Weidner, W.J., Jones, G.A. and Scott, J.B. (1975) Vascular responses in the equine digit. Am. J. vet. Res. 36, 1249-1253.
40. Robinson, N.E., Derksen, F.J., Olszewski, M., Berney, C., Boehler, D., Matson, C. and Hakala, J. (1999) Determinants of the maximal change in pleural pressure during tidal breathing in COPD-affected horses. Vet. J. 157, 160-165.
41. Roubert, P., Viossat, I., Lonchampt, M.O., Chapelat, M., Schulz, J., Plas, P., Gillard-Roubert, V., Chabrier, P.E. and Braquet, P. (1993) Endothelin receptor regulation by endothelin synthesis in vascular smooth muscle cells: effects of dexamethasone and phosphoramidon. J. Vasc. Res. 30, 139-144.
42. Ryu, S.H., Kim, B.S., Lee, C.W., Yoon, J. and Lee, Y.L. (2004) Glucocorticoid-induced laminitis with hepatopathy in a Thoroughbred filly. J. vet. Sci. 5, 271-274.
43. Sakaue, M. and Hoffman, B.B. (1991) Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells. J. clin. Invest. 88, 385-389.
44. Severino, C., Brizzi, P., Solinas, A., Secchi, G., Maioli, M. and Tonolo, G. (2002) Low-dose dexamethasone in the rat: a model to study insulin resistance. Am. J. Physiol. Endocrinol. Metab. 283, E367-373.
45. Shastry, S., Minson, C.T., Wilson, S.A., Dietz, N.M. and Joyner, M.J. (2000) Effects of atropine and L-NAME on cutaneous blood flow during body heating in humans. J. appl. Physiol. 88, 467-472.
46. Sommer, A., Veraart, J., Neumann, M. and Kessels, A. (1998) Evaluation of the vasoconstrictive effects of topical steroids by laser-Doppler-perfusion- imaging. Acta Derm. Venereol. 78, 15-18.
47. Stepp, D.W. and Frisbee, J.C. (2002) Augmented adrenergic vasoconstriction in hypertensive diabetic obese Zucker rats. Am. J. Physiol. Heart Circ. Physiol. 282, H816-820.
48. Tooke, J. (1999) The association between insulin resistance and endotheliopathy. Diabetes Obes. Metab. 1 Suppl. 1, S17-22.
49. Tooke, J.E. and Goh, K.L. (1999) Vascular function in Type 2 diabetes mellitus and pre-diabetes: the case for intrinsic endotheiopathy. Diabet. Med. 16, 710-715.
50. Venugopal, C.S., Holmes, E.P., Koch, C.E., Curtis, L.A., Holm, A.S. and Moore, R.M. (2001) In vitro pharmacologic effect of two endothelin-1 antagonists on equine colonic arteries and veins. Am. J. vet. Res. 62, 154-159.
51. Wallerath, T., Godecke, A., Molojavyi, A., Li, H., Schrader, J. and Forstermann, U. (2004) Dexamethasone lacks effect on blood pressure in mice with a disrupted endothelial NO synthase gene. Nitric Oxide 10, 36-41.
52. Wallerath, T., Witte, K., Schafer, S.C., Schwarz, P.M., Prellwitz, W., Wohlfart, P., Kleinert, H., Lehr, H.A., Lemmer, B. and Forstermann, U. (1999) Down-regulation of the expression of endothelial NO synthase is likely to contribute to glucocorticoid-mediated hypertension. Proc. Natl. Acad. Sci. USA 96, 13357-13362.
53. Wenzel, R.R., Ruthemann, J., Bruck, H., Schafers, R.F., Michel, M.C. and Philipp, T. (2001) Endothelin-A receptor antagonist inhibits angiotensin II and noradrenaline in man. Br. J. Clin. Pharmacol. 52, 151-157.
54. Wilson, T.E., Monahan, K.D., Short, D.S. and Ray, C.A. (2004) Effect of age on cutaneous vasoconstrictor responses to norepinephrine in humans. Am. J. Physiol. Regul. Integr. Comp. Physiol. 287, R1230-1234.
55. Yosipovitch, G., Sackett-Lundeen, L., Goon, A., Yiong Huak, C., Leok Goh, C. and Haus, E. (2004) Circadian and ultradian (12 h) variations of skin blood flow and barrier function in non-irritated and irritated skin-effect of topical corticosteroids. J. Invest. Dermatol. 122, 824-829.